How are geopolitical factors influencing sourcing and manufacturing decisions for 2026 and beyond?
Geopolitical developments are influencing how biopharmaceutical companies approach sourcing and manufacturing for 2026 and beyond. Trade policy shifts, supply chain vulnerabilities, and regional conflicts are prompting organizations to reassess production locations and supplier relationships. In a Pharma's Almanac roundtable, James Choi, EVP and Head of Global Public Affairs, discusses these dynamics and their implications for the industry, including approaches to building resilience and managing operational risk.
Read the full article here for the complete discussion.
Geopolitical developments are influencing how biopharmaceutical companies approach sourcing and manufacturing for 2026 and beyond. Trade policy shifts, supply chain vulnerabilities, and regional conflicts are prompting organizations to reassess production locations and supplier relationships. In a Pharma's Almanac roundtable, James Choi, EVP and Head of Global Public Affairs, discusses these dynamics and their implications for the industry, including approaches to building resilience and managing operational risk.
Read the full article here for the complete discussion.
Share article
Related Content